Mirae Asset Global ETFs Holdings’s Aldeyra Therapeutics ALDX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ALDX Stock Details ALDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-25,815	Closed	-$43.6K	–	3172
2026 Q1	$43.6K	Buy	25,815 +612	+2%	+$2.68K	﹤0.01%	2940
2025 Q4	$131K	Sell	25,203 -295	-1%	-$1.52K	﹤0.01%	2554
2025 Q3	$133K	Sell	25,498 -3,094	-11%	-$16.1K	﹤0.01%	2536
2025 Q2	$110K	Sell	28,592 -1,248	-4%	-$3.23K	﹤0.01%	2569
2025 Q1	$172K	Buy	29,840 +1,248	+4%	+$7.38K	﹤0.01%	2397
2024 Q4	$143K	Buy	28,592 +1,515	+6%	+$7.77K	﹤0.01%	2554
2024 Q3	$146K	Buy	27,077 +2,672	+11%	+$12.7K	﹤0.01%	2530
2024 Q2	$80.8K	Buy	+24,405	New	+$95.6K	﹤0.01%	2648

Other funds holding ALDX

KCM

Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ALDX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings sold out of Aldeyra Therapeutics (ALDX) in Q2 2026, closing a stake of 25,815 shares — an estimated $43.6K sold.

Mirae Asset Global ETFs Holdings first reported a position in ALDX in Q2 2024 and held it in 8 quarters. The position peaked at $172K in Q1 2025. 107 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

Mirae Asset Global ETFs Holdings reported no remaining Aldeyra Therapeutics position as of Q2 2026 after selling out during the quarter.
Mirae Asset Global ETFs Holdings sold 25,815 Aldeyra Therapeutics shares in Q2 2026, an estimated $43.6K.
Mirae Asset Global ETFs Holdings first reported a position in Aldeyra Therapeutics in Q2 2024 and held it in 8 quarters.
Mirae Asset Global ETFs Holdings's Aldeyra Therapeutics position peaked at $172K in Q1 2025.
107 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.